BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 38748269)

  • 1. The predictive value of delta-like3 and serum NSE in evaluating chemotherapy response and prognosis in patients with advanced small cell lung carcinoma: An observational study.
    Zhu C; Huang J; Jin X; Zhang C; Zhu C; Lv M; Chen S; Du X; Feng G
    Medicine (Baltimore); 2024 Jun; 103(23):e38487. PubMed ID: 38847733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer.
    Li DM; Li GS; Li JD; Chen F; Huang H; Huang WY; Huang ZG; Dang YW; Tang YL; Tang ZQ; Tang WJ; Chen G; Lu HP
    Clin Transl Oncol; 2024 Jun; 26(6):1519-1531. PubMed ID: 38206516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities and Underutilization of Surgery for Early Stage Small Cell Lung Cancer.
    Fong AJ; Reich H; Mirocha J; Wong A; Imai TA
    Ann Thorac Surg; 2024 Jun; 117(6):1095-1102. PubMed ID: 38281575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.
    Fu M; Feng C; Wang J; Guo C; Wang Y; Gao R; Wang J; Zhu Q; Zhang X; Qi J; Zhang Y; Bian Y; Wang Z; Fang Y; Cao L; Hong B; Wang H
    Clin Exp Med; 2024 May; 24(1):99. PubMed ID: 38748269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion.
    Zhang L; Liu C; Zhang B; Zheng J; Singh PK; Bshara W; Wang J; Gomez EC; Zhang X; Wang Y; Zhu X; Goodrich DW
    J Thorac Oncol; 2023 Mar; 18(3):324-338. PubMed ID: 36473627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer.
    Lang C; Lantos A; Megyesfalvi Z; Egger F; Hoda MA; Mosleh B; Klikovits T; Oberndorfer F; Timelthaler G; Ferencz B; Fillinger J; Schwendenwein A; Querner AS; Boettiger K; Renyi-Vamos F; Hoetzenecker K; Laszlo V; Schelch K; Dome B
    ESMO Open; 2022 Dec; 7(6):100631. PubMed ID: 36399951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Notch signaling pathway and its correlation with immune microenvironment in SCLC.
    Li W; Ye L; Huang Y; Zhou F; Wu C; Wu F; He Y; Li X; Wang H; Xiong A; Gao G; Wang L; Su C; Ren S; Chen X; Zhou C
    Lung Cancer; 2022 May; 167():25-33. PubMed ID: 35381444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ganti AKP; Loo BW; Bassetti M; Blakely C; Chiang A; D'Amico TA; D'Avella C; Dowlati A; Downey RJ; Edelman M; Florsheim C; Gold KA; Goldman JW; Grecula JC; Hann C; Iams W; Iyengar P; Kelly K; Khalil M; Koczywas M; Merritt RE; Mohindra N; Molina J; Moran C; Pokharel S; Puri S; Qin A; Rusthoven C; Sands J; Santana-Davila R; Shafique M; Waqar SN; Gregory KM; Hughes M
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1441-1464. PubMed ID: 34902832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer.
    Li D; Deng C; Zheng Q; Fu F; Wang S; Li Y; Chen H; Zhang Y
    Front Oncol; 2021; 11():704517. PubMed ID: 34631534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.
    Roper N; Velez MJ; Chiappori A; Kim YS; Wei JS; Sindiri S; Takahashi N; Mulford D; Kumar S; Ylaya K; Trindade C; Manukyan I; Brown AL; Trepel JB; Lee JM; Hewitt S; Khan J; Thomas A
    Nat Commun; 2021 Jun; 12(1):3880. PubMed ID: 34162872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis.
    Ye P; Guo Z; Zhang Y; Dong C; Li M
    Front Oncol; 2021; 11():676598. PubMed ID: 34079765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dingemans AC; Früh M; Ardizzoni A; Besse B; Faivre-Finn C; Hendriks LE; Lantuejoul S; Peters S; Reguart N; Rudin CM; De Ruysscher D; Van Schil PE; Vansteenkiste J; Reck M;
    Ann Oncol; 2021 Jul; 32(7):839-853. PubMed ID: 33864941
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential Expression of PD-L1 in Central and Peripheral and TTF1-Positive and -Negative Small-Cell Lung Cancer.
    Yu S; Jia M; Li Y; Sun PL; Gao H
    Front Med (Lausanne); 2020; 7():621838. PubMed ID: 33585516
    [No Abstract]   [Full Text] [Related]  

  • 15. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
    Gay CM; Stewart CA; Park EM; Diao L; Groves SM; Heeke S; Nabet BY; Fujimoto J; Solis LM; Lu W; Xi Y; Cardnell RJ; Wang Q; Fabbri G; Cargill KR; Vokes NI; Ramkumar K; Zhang B; Della Corte CM; Robson P; Swisher SG; Roth JA; Glisson BS; Shames DS; Wistuba II; Wang J; Quaranta V; Minna J; Heymach JV; Byers LA
    Cancer Cell; 2021 Mar; 39(3):346-360.e7. PubMed ID: 33482121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-cell lung cancer.
    Rudin CM; Brambilla E; Faivre-Finn C; Sage J
    Nat Rev Dis Primers; 2021 Jan; 7(1):3. PubMed ID: 33446664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of survival following surgical resection of limited-stage small cell lung cancer.
    Zhou N; Bott M; Park BJ; Vallières E; Wilshire CL; Yasufuku K; Spicer JD; Jones DR; Sepesi B;
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):760-771.e2. PubMed ID: 33349449
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.